Anon.: CDC AIDS Weekly, p. 6. May 20, 1991 (1991a).
2.
Anon.: CDC AIDS Weekly, p. 11, 12. March 11, 1991 (1991b).
3.
Archibald, D.W., L. Zon, J.E. Groopman, M.F. McLane, and M. Essex: Antibodies to Human T-Lymphotropic Virus Type III (HTLV-III) in Saliva of Acquired Immunodeficiency Syndrome (AIDS) Patients and in Persons at Risk for AIDS. Blood67:831-834 (1986).
4.
Archibald, D.W., C.E. Barr, J.P. Torosian, M.F. McLane, and M. Essex: Secretory IgA Antibodies to Human Immunodeficiency Virus in the Parotid Saliva of Patients with AIDS and AIDS-Related Complex, J. Infect. Dis. 155:793-796 (1987).
5.
Archibald, D.W., J.P. Johnson, P. Nair, L.S. Alger, C.A. Hebert, E. Davis, and S.E. Hines: Detection of Salivary Immunoglobulin A Antibodies to HIV-1 in Infants and Children. AIDS4:417-420 (1990).
6.
Archibald, D.W. and G.A. Cole: In Vitro Inhibition of HIV-1 Infectivity by Human Salivas. AIDS Res. Human Retroviruses6:1425-1432 (1990 ).
7.
Brandtzaeg, P.: Salivary Immunoglobulins. In: Human Saliva: Clinical Chemistry and Microbiology, Vol. II, pp. 1-54. (J. O. Tenovuo, Ed.) CRC Press, Boca Raton ( 1989).
8.
Crofts, N., S. Nicholson, P. Coghlan, and I.D. Gust: Testing of Saliva for Antibodies to HIV-1. AIDS5:561-563 (1991).
9.
Fox, P.C. and B.J. Baum: Isolation of HTLV-III Virus from Saliva in AIDS. N. Engl. J. Med. 314:1387 (1986).
10.
Fox, P.C., A. Wolff, C.K. Yeh, J.C. Atkinson, and B.J. Baum: Saliva Inhibits HIV-1 Infectivity. J. Am. Dent. Assoc. 118:635-637 (1988).
11.
Fox, P.C., A. Wolff, C.K. Yeh, J.C. Atkinson and B.J. Baum: Salivary Inhibition of HIV-1 Infectivity: Functional Properties and Distribution in Men, Women, and Children. J. Am. Dent. Assoc.118:709-711 (1989).
12.
Francis, T. and E. Minuse: Influence of Saliva upon Hemagglutination by Influenza Virus. Proc. Soc. Exp. Biol. Med. 69:291-294 (1948).
13.
Fultz, P.N.: Components of Saliva Inactivate Human Immunodeficiency Virus. Lancetii:1215 (1986).
14.
Goto, Y., C.K. Yeh, A.L. Notkins, and B.S. Prabhaker: Detection of Proviral Sequences in Saliva of Patients Infected with Human Immunodeficiency Virus Type 1. AIDS Res. Human Retroviruses7:343-347 (1991).
15.
Groopman, J.E., S.Z. Salahuddin, M.G. Samgadharan, P.D. Markham, M. Gonda, A. Sliski, and R.C. Gallo: HTLV-III in Saliva of People with AIDS-Related Complex and Healthy Homosexual Men at Risk for AIDS. Science226:447-449 (1984).
16.
Heineman, H.S. and M.S. Greenberg: Cell-Protective Effect of Human Saliva Specific for Herpes Simplex Virus. Arch. Oral Biol. 25:257-261 (1980).
17.
Ho, D.D., B.S. Byington, R.T. Schooley, T. Flynn, T.R. Rota, and M.S. Hirsch: Infrequency of Isolation of HTLV-III Virus from Saliva in AIDS. N. Engl. J. Med. 313:1606 (1985).
18.
Holmstrom, P., S. Syrjanen, P. Laine, S.-L. Valle, and J. Suni: HIV Antibodies in Whole Saliva Detected by ELISA and Western Blot Assays. J. Med. Virol. 30:245-248 (1990).
19.
Johnson, A.M., J.V.Parry, S.J.Best, A.M. Smith, M.De Silva, and P.P. Mortimer: HIV Surveillance by Testing Saliva, AIDS2:369-371 (1988).
20.
Lerner, A.M., E.J. Bailey, and M. Kofender: Preparations of Saliva Inhibiting Reovirus Hemagglutination. J. Immunol. 96:59-63 (1966).
21.
Levy, J.A. and D. Greenspan: HIV in Saliva. Lancet2:1248 (1988).
22.
Major, C.J., S.E. Read, R.A. Coates, A. Francis, B.J. McLauglin, M. Millson, F. Shepherd, M. Fanning, L. Calzavara, D. MacFadden, J.K. Johnson, and M.V. O'Shaughnessy: Comparison of Saliva and Blood for Human Immunodeficiency Virus Prevalence Testing. J. Infect. Dis.163:699-702 (1991).
23.
Malamud, D., C.A. Davis, E. Roth, and H. Friedman: HIV Inhibitory Factors in Human Saliva. VII International Conference on AIDS MA 1248, p. 154 (1991).
24.
O'Shea, S., M. Cordery, W.Y. Barrett, D.D. Richman, C. Bradbeer, and J.E. Banatvala: HIV Excretion Patterns and Specific Antibody Responses in Body Fluids. J. Med. Virol. 31:291-296 (1990).
25.
Ou, C.-Y., C.A. Ciesielski, G. Myers, C.I. Bandea, et al.: Molecular Epidemiology of HIV Transmission in a Dental Practice. Science256:1165-1171 (1992 ).
26.
Parry, J.V., K.R. Perry, and P.P. Mortimer: Sensitive Assays for Viral Antibodies in Saliva: An Alternative to Tests on Serum. Lancet2:72-75 (1987).
27.
Pekovic, D., D. Ajdukovic, C. Tsoukas, N. Lapointe, J. Michaud, N. Gilmore, and M. Gornitsky: Detection of Human Immunosuppressive Virus in Salivary Lymphocytes from Dental Patients with AIDS. Am. J. Med. 82:188-189 (1987).
28.
Pourtois, M., C. Binet, N. Van Tieghem, P. Courtois, A. Vandenabbeele, and L. Thiry: Inhibition of HIV Infectivity by Lactoperoxidase-Produced Hypothiocyanite. J. Biol. Buccale18:251-253 (1990).
29.
Shoeman, R.L., R. Pottathil, and C. Metroka: Antibodies to HIV in Saliva. N. Engl. J. Med. 320:1145-1146 (1989).
30.
Su, H. and R.J. Boackle: Interaction of the Envelope Glycoprotein of Human Immunodeficiency Virus with Clq and Fibronectin under Conditions Present in Human Saliva. Mol. Immunol. 28:811-817 (1991).
31.
Sun, D., D.W. Archibald, and P.A. Furth: Variation of Secretory Antibodies in Parotid Saliva to Human Immunodeficiency Virus Type 1 with HIV-1 Disease Stage. AIDS Res. Human Retroviruses6:933-941 (1990).
32.
Vasudevachari, M.B., K. Uffelman, P.F. Pierce, H.C. Lane, and N.P. Salzman: Detection of Antibodies to Human Immunodeficiency Virus Type 1 in Whole Blood and Saliva by Using a Passive Hemagglutination Test. J. Clin. Microbiol. 27:2384-2385 (1989).
